Should I buy or sell Azenta stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last twelve months. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AZTA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AZTA, but not buy additional shares or sell existing shares. View AZTA analyst ratings or view top-rated stocks .

What is Azenta's stock price target for 2024?

6 brokerages have issued twelve-month target prices for Azenta's stock. Their AZTA share price targets range from $60.00 to $79.00. On average, they anticipate the company's stock price to reach $69.60 in the next year. This suggests a possible upside of 37.3% from the stock's current price. View analysts price targets for AZTA or view top-rated stocks among Wall Street analysts .

How have AZTA shares performed in 2024?

Azenta's stock was trading at $65.14 on January 1st, 2024. Since then, AZTA stock has decreased by 22.2% and is now trading at $50.68. View the best growth stocks for 2024 here .

When is Azenta's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our AZTA earnings forecast .

How were Azenta's earnings last quarter?

Azenta, Inc. (NASDAQ:AZTA) posted its quarterly earnings results on Wednesday, February, 7th. The company reported $0.02 EPS for the quarter. The business earned $154.32 million during the quarter, compared to analysts' expectations of $151.86 million. Azenta had a negative net margin of 2.92% and a positive trailing twelve-month return on equity of 0.49%.

What ETFs hold Azenta's stock?

ETFs with the largest weight of Azenta (NASDAQ:AZTA) stock in their portfolio include ROBO Global Healthcare Technology and Innovation ETF (HTEC) , ROBO Global Robotics & Automation ETF (ROBO) , Principal Healthcare Innovators ETF (BTEC) and BlackRock Future Innovators ETF (BFTR) . Syntax Stratified MidCap ETF (SMDY) .

What guidance has Azenta issued on next quarter's earnings?

Azenta issued an update on its FY 2024 earnings guidance on Thursday, March, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $696.0 million-$718.0 million, compared to the consensus revenue estimate of $703.6 million.

Who are Azenta's major shareholders?

Azenta's stock is owned by many different retail and institutional investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.90%), State of Michigan Retirement System (0.02%), Park Avenue Securities LLC (0.02%), Roble Belko & Company Inc (0.01%) and Handelsinvest Investeringsforvaltning (0.01%). Insiders that own company stock include David C Gray , Jesus Linda De , Kimberly Crowley , Lindon G Robertson and Matthew Mcmanus. View institutional ownership trends .

How do I buy shares of Azenta?

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:AZTA

Azenta (AZTA) Stock Price, News & Analysis

→ Urgent alert: open this for a huge profit potential (From Timothy Sykes) (Ad)

Free AZTA Stock Alerts

$50.40

-0.09 (-0.18%)

(As of 12:51 PM ET)

Compare

Today's Range: $50.15
▼
$50.94
50-Day Range: $50.49
▼
$67.30
52-Week Range: $36.01
▼
$69.16

Volume: 140,415 shs
Average Volume: 424,344 shs
Market Capitalization: $2.81 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $69.60

Get Azenta alerts:

Azenta MarketRank™ Stock Analysis

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 37.3% Upside
$69.60 Price Target
Short Interest: Bearish
7.61% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.09
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 85.19%
From $0.27 to $0.50 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.02 out of 5 stars

Medical Sector

351st out of 918 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

7th out of 13 stocks

4.2

Analyst's Opinion

Consensus Rating
Azenta has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Azenta has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

1.0

Short Interest

Percentage of Shares Shorted
7.61% of the float of Azenta has been sold short.
Short Interest Ratio / Days to Cover
Azenta has a short interest ratio ("days to cover") of 9.6.
Change versus previous month
Short interest in Azenta has recently increased by 0.48%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Azenta does not currently pay a dividend.
Dividend Growth
Azenta does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AZTA.

2.3

News and Social Media Coverage

News Sentiment
Azenta has a news sentiment score of 1.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Azenta this week, compared to 4 articles on an average week.
MarketBeat Follows
Only 1 people have added Azenta to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Azenta insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.77% of the stock of Azenta is held by insiders.
Percentage Held by Institutions
99.08% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Azenta are expected to grow by 85.19% in the coming year, from $0.27 to $0.50 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Azenta is -163.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Azenta is -163.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Azenta has a P/B Ratio of 1.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Timothy Sykes

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

About Azenta Stock (NASDAQ:AZTA)

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

AZTA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AZTA Stock News Headlines

April 15, 2024 | nasdaq.com

Azenta is Now Oversold (AZTA)

April 12, 2024 | americanbankingnews.com

Azenta, Inc. (NASDAQ:AZTA) Receives Consensus Recommendation of "Hold" from Analysts

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 10, 2024 | americanbankingnews.com

Azenta (NASDAQ:AZTA) Stock Rating Reaffirmed by Needham & Company LLC

April 1, 2024 | prnewswire.com

Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report

April 1, 2024 | prnewswire.com

Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference

March 28, 2024 | markets.businessinsider.com

Decoding 7 Analyst Evaluations For Azenta

March 13, 2024 | seekingalpha.com

Genscript Biotech GAAP EPS of -$0.045, revenue of $839.5M misses by $460.5M

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 12, 2024 | finance.yahoo.com

Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum

March 7, 2024 | markets.businessinsider.com

Buy Rating Affirmed: Azenta’s Strong Financial Outlook and Strategic Growth Trajectory

March 7, 2024 | markets.businessinsider.com

In-Depth Examination Of 5 Analyst Recommendations For Azenta

February 24, 2024 | msn.com

Azenta (AZTA) Price Target Increased by 9.92% to 73.44

February 23, 2024 | benzinga.com

Azenta Stock (NASDAQ:AZTA), Analyst Ratings, Price Targets, Predictions

February 23, 2024 | benzinga.com

Azenta Stock (NASDAQ:AZTA) Earnings Dates and Earning Calls

February 8, 2024 | markets.businessinsider.com

Strong Buy Rating for Azenta, Inc. Amid Growth and Strategic Initiatives

February 7, 2024 | seekingalpha.com

Azenta, Inc. 2024 Q1 - Results - Earnings Call Presentation

February 7, 2024 | benzinga.com

Azenta: Q1 Earnings Insights

February 7, 2024 | finance.yahoo.com

Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023

February 7, 2024 | finance.yahoo.com

Azenta Inc (AZTA) Faces Revenue Decline and EPS Drop in Q1 Fiscal 2024

February 6, 2024 | msn.com

Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates

February 6, 2024 | benzinga.com

Preview: Azenta's Earnings

February 2, 2024 | finanznachrichten.de

Azenta Launches the BioArc Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management

February 2, 2024 | finance.yahoo.com

Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management

January 31, 2024 | sg.news.yahoo.com

Melanie Griffith and Antonio Banderas Support Dakota Johnson at “SNL” Afterparty

January 29, 2024 | bizjournals.com

Natural gas utility Spire names new chairman

January 28, 2024 | finance.yahoo.com

Investors in Azenta (NASDAQ:AZTA) have seen impressive returns of 117% over the past five years

See More Headlines

Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/07/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Special industry machinery, not elsewhere classified
Sub-Industry: N/A
Current Symbol: NASDAQ:AZTA
CUSIP: N/A
CIK: 933974
Web: www.brooks.com
Phone: (978) 262-2400
Fax: 978-262-2500
Employees: 3,500
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $69.60
High Stock Price Target: $79.00
Low Stock Price Target: $60.00
Potential Upside/Downside: +37.8%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.31)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 187.00
P/E Growth: N/A
Net Income: $-14,260,000.00
Net Margins: -2.92%
Pretax Margin: -4.75%
Return on Equity: 0.49%
Return on Assets: 0.43%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.87
Quick Ratio: 5.33

Sales & Book Value

Annual Sales: $665.07 million
Price / Sales: 4.23
Cash Flow: $1.61 per share
Price / Cash Flow: 31.33
Book Value: $42.10 per share
Price / Book: 1.20

Miscellaneous

Outstanding Shares: 55,760,000
Free Float: 54,778,000
Market Cap: $2.82 billion
Optionable: Optionable
Beta: 1.53

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Dr. Stephen S. Schwartz (Age 65)
CEO, President & Director
Comp: $1.05M
Mr. Robin Vacha (Age 48)
Senior Vice President of Global Operations
Comp: $533.35k
Mr. Jason W. Joseph (Age 53)
Senior VP, General Counsel & Corporate Secretary
Comp: $544.13k
Mr. Herman Cueto (Age 50)
Executive VP & CFO
Ms. Violetta Hughes (Age 52)
VP & Chief Accounting Officer
Mr. Michael Paulo
VP and Chief Information & Digital Officer
Mr. John E. O'Brien (Age 54)
Senior Vice President of Corporate Development
Ms. Olga Pirogova (Age 50)
Senior VP & Chief HR Officer
Mr. J. Robert Woodward
Senior Vice President of Global Quality & Regulatory
Dr. Ginger Zhou Ph.D. (Age 47)
Senior VP & GM of Multiomics and Synthesis Solutions

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

AZTA Stock Analysis - Frequently Asked Questions

Should I buy or sell Azenta stock right now?: 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last twelve months. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AZTA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AZTA, but not buy additional shares or sell existing shares.
View AZTA analyst ratings or view top-rated stocks.
What is Azenta's stock price target for 2024?: 6 brokerages have issued twelve-month target prices for Azenta's stock. Their AZTA share price targets range from $60.00 to $79.00. On average, they anticipate the company's stock price to reach $69.60 in the next year. This suggests a possible upside of 37.3% from the stock's current price.
View analysts price targets for AZTA or view top-rated stocks among Wall Street analysts.
How have AZTA shares performed in 2024?: Azenta's stock was trading at $65.14 on January 1st, 2024. Since then, AZTA stock has decreased by 22.2% and is now trading at $50.68.
View the best growth stocks for 2024 here.
When is Azenta's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our AZTA earnings forecast.
How were Azenta's earnings last quarter?: Azenta, Inc. (NASDAQ:AZTA) posted its quarterly earnings results on Wednesday, February, 7th. The company reported $0.02 EPS for the quarter. The business earned $154.32 million during the quarter, compared to analysts' expectations of $151.86 million. Azenta had a negative net margin of 2.92% and a positive trailing twelve-month return on equity of 0.49%.

What ETFs hold Azenta's stock?: ETFs with the largest weight of Azenta (NASDAQ:AZTA) stock in their portfolio include ROBO Global Healthcare Technology and Innovation ETF (HTEC), ROBO Global Robotics & Automation ETF (ROBO), Principal Healthcare Innovators ETF (BTEC) and BlackRock Future Innovators ETF (BFTR).Syntax Stratified MidCap ETF (SMDY).
What guidance has Azenta issued on next quarter's earnings?: Azenta issued an update on its FY 2024 earnings guidance on Thursday, March, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $696.0 million-$718.0 million, compared to the consensus revenue estimate of $703.6 million.
Who are Azenta's major shareholders?: Azenta's stock is owned by many different retail and institutional investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.90%), State of Michigan Retirement System (0.02%), Park Avenue Securities LLC (0.02%), Roble Belko & Company Inc (0.01%) and Handelsinvest Investeringsforvaltning (0.01%). Insiders that own company stock include David C Gray, Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus.
View institutional ownership trends.
How do I buy shares of Azenta?: Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AZTA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial